Towards Healthcare
Breast Cancer Screening Tests Market Size Reaches USD 4.75 Billion in 2025

Breast Cancer Screening Tests Market Growth Accelerates in 2025 Fueled by AI, Rural Access and PEM Advancements

Market insights predict, the breast cancer screening tests industry is expected to grow from USD 4.44 billion in 2024 to USD 8.77 billion by 2034, driven by a CAGR of 7.04%. The breast cancer screening tests market is growing due to its major applications, including mammography, breast ultrasound, breast MRI, clinical breast examination (CBE), breast self-examination (BSE), and biopsy. North America is dominated by the market, driven by improved treatment options and early detection technology.

Content

  • Insight Code: 5847
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The breast cancer screening tests market is projected to reach USD 8.77 billion by 2034, growing at a CAGR of 7.04% from 2024 to 2034.

North America is currently leading the breast cancer screening tests market due to the growing awareness of cancer and increasing government support.

The breast cancer screening tests market includes six segments such as by test type, by sample type, by collection, by application, by end user, and by region.

Some key players include Hologic Inc., Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems.

Key trends include the advancement in modern screening tests and the increasing prevalence of breast cancer.

NHS England has introduced a new target called the Faster Diagnosis Standard (FDS). The target is that they should not wait more than 28 days from referral to finding out whether they have cancer or not.

Researchers say the reasons for the rising incidence in younger women are complex and multifactorial changing childbearing and breastfeeding patterns, increased alcohol use, excess body weight, genetics, environmental exposures, and more.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions